The effects of fundic vagotomy on acid and pepsin secretion in 12 patients (10 males, two females; nine duodenal ulcer, three gastric ulcer) were studied using a pentagastrin dose response before and after vagotomy. In the intact state H, Cl, and pepsin output all had the same ED50, 120-127 pmol/kg/h. Vagotomy reduced basal output of acid by 78%, Cl-by 50%, and pepsin by 62%. Postvagotomy basal outputs were not related to preoperative levels, while maximum acid output was reduced by an average of 35%, proportionally to the preoperative output (r=0.94). Vagotomy uncompetitively (ED50 increase, Vmax decrease) inhibited the pentagastrin dose response of acid, chloride, and pepsin output. Postoperatively, a six-fold greater dose of pentagastrin (450 vs 76 pmollkg/h) was required to stimulate acid to 50% of its preoperative maximum output. For pepsin secretion the increase was 12-fold (185 vs 15 pmol/kg/h). In five of the nine duodenal ulcer patients pentagastrin dose responses were repeated with a background infusion of urecholine, 20 ,ug/kg/h. Urecholine increased basal and peak acid, pepsin, and chloride outputs, and the ratio of basal:maximal almost to prevagotomy levels; it also restored the sensitivity to pentagastrin. Serum gastrin was not significantly changed by urecholine or by vagotomy. We conclude that the level of basal acid and pepsin secretion in ulcer patients, which is largely eliminated by vagotomy, is dependent on the vagus and not on serum gastrin. The effects of vagotomy are functional, are due to cholinergic withdrawal, and usually can be restored by cholinergic replacement. Fundic (highly selective) vagotomy is an established and important treatment for duodenal ulcer. The effect of vagotomy on acid secretion has been extensively investigated in man and animals, but there are only scanty data on pepsin secretion.1 4
study of gastric secretion, they have rarely been used to study the effects of vagotomy in man.
In man a cholinergic background generally restores to prevagotomy levels the maximum acid response to histamine. Roland et al 19 however, could not confirm this for pentagastrin. The cholinergic agents apparently do not increase the maximum levels attainable with pentagastrin or histamine intact in man,>10 as they do in the dog.' 2
We used the pentagastrin dose response before and after surgery to analyse the effects of fundic vagotomy on basal and stimulated acid and pepsin secretion, and on the kinetics of response to pentagastrin. We sought to determine whether the effects of vagotomy could be reversed by a cholinergic background. From this information we hoped better to understand the role of the vagus in gastric secretion in ulcer disease. 675
Methods
The study was approved by the Institutional Review Board for Human Experimentation and all the patients agreed to the studies after being informed of their purpose and methods.
Ten men and two women, aged 19 to 53 years (mean 37 years, SE±3.6), nine with duodenal and three with gastric ulcer had pentagastrin doseresponse gastric secretion studies before and one to nine (mean 3±0.8) months after fundic vagotomy (highly selective vagotomy). They weighed 66.7 kg±4 before and 66.3 kg±3-8 after vagotomy.
In five of the nine duodenal ulcer subjects after vagotomy pentagastrin dose-response studies were also performed with a background of urecholine (bethanechol) 20 ug/kg/h. Three of these patients were studied again three to four years after vagotomy with new pentagastrin control studies, so that the paired studies in this group (pentagastrin dose-response ± urecholine) were performed within a week of each other. A small but not significant increase in acid and pepsin outputs occurred during the interval between the two postoperative studies.
Each study was carried out in the fasting state, more than 10 hours after the evening meal. All antisecretory drugs were withdrawn at least 36 hours before study. A Salem sump nasogastric tube was positioned fluoroscopically or by the method of Hassan and Hobsley,18 and connected to moderate suction supplemented by syringe suction at intervals. Saliva was aspirated continuously by a dental suction device. After the fasting residue was removed and measured, timed consecutive 10 minute samples were collected. After 40 minutes in the basal state, pentagastrin (Peptavlon, Ayerst, M.W. 767) was given from a Harvard syringe pump in doses of 0.1, 0-25, 1-0, and 2.5 ,ug/kg/h in successive 40 minute periods. Acid was titrated to pH 7-0 with 0.04 N NaOH; chloride was measured by a Coming coulometric chloridimeter and pepsin by an automated protein digestion method' using haemoglobin substrate in which 1,ug crystallised pepsinogen (Sigma Chemical Co, St Louis, MO) has the activity of four peptic units: 1000 peptic units equal 1 peptic kilo unit.
STATISTICAL ANALYSIS
To allow for equilibration, output for each dose step was calculated from the last three 10 minute samples in each 40 minute period. Data for individual subjects were compared by paired t test; linear correlations were performed for groups of paired data. A value of p<O05 was considered significant. Dose responses were analysed by an exponential model V=Vmax-becs,* incorporating statistical analyses, so that the significance of the fit and the derived data, threshold (T), Km, ED50, and Vmax could be determined.'2 Where output is present before a stimulus is appliedfor example, basal secretion in manthe exponential model provides the best analyses of the dose response. Here the basal secretion can be described as that which would result from the equivalent of a calculated dose (T) of the drug subsequently given in graded doses. This is analagous to determining the concentration of a constituent in solution by measuring the change resulting from the addition of known increments of the same constituents and extrapolating back to 0.
Results

FUNDIC VAGOTOMY
Dose response
Vagotomy reduced mean basal acid output by 78%, chloride by 50%, and pepsin by 62% (Table 1) . Stimulated acid, chloride, and pepsin output curves were displaced downwards parallel to the prevagotomy curves, with reduction of the maximum outputs by about 35% (Figs 1, 2 ). With Vmax decreased, ED50 almost doubled for H' and Cland increased by 50% for pepsinthat is, vagotomy produced an uncompetitive inhibition12 of the pentagastrin dose-response. With the reduction of ratios of basal:maximum output, T, as a fraction of ED5o, was proportionately decreased (Table 1) .
Taking into consideration the reduction in maximum outputs, the effect of vagotomy on secretion was even more profound when we calculated the amount of pentagastrin required to stimulate the stomach to secrete 50% of the maximum prevagotomy output of acid (19 mmol/h) and pepsin (300 KU) ( Fig 1) . For acid the increase was six-fold (450 vs 76 pmol/kg/h) and for pepsin 12-fold (185 vs 15 pmol/kg/h).
Basal and maximal outputs
The effects of vagotomy were also examined in the conventional way by comparing basal and maximal outputs in individual patients. Basal outputs, especially the larger outputs, were markedly reduced in 10 of the 12 patients. Postvagotomy values were not related to preoperative levels (r=0.09 and -0.06 respectively for acid and pepsin) ( Fig 2) . Individual basal acid and pepsin outputs as a percentage of maximum outputs were lower after * V = output of H+, pepsin, etc; S = dose of stimulant; T = calculated threshold = c/b; Km = dose of exogenous stimulant required to stimulate output to 50% of calculated maximum (Vmax); c and b are calculated constants. ED50 is the total dose which would be required to stimulate output to 50% of maximum, if there were no basal output. Km -T = EDso. 
Dose responses
Urecholine reversed the effects of vagotomy, producing a parallel upward displacement of the pentagastrin dose response of both acid and pepsin outputs to levels not significantly different from prevagotomy (Fig 6) . Urecholine also restored T, Km, and ED50 to or below preoperative levels ( Table 2) , and produced these effects by raising basal secretion, thus increasing T and reducing Kmthat is, increasing the sensitivity to pentagastrin.
Basal and peak outputs Basal acid output, peak acid output, and the ratio of basal acid output:peak acid output that were significantly depressed by vagotomy (p<005) were restored to between 84 and 93% of preoperative levels. Similar urecholine effects were seen on chloride and pepsin secretion, with restoration to 92-100% of prevagotomy basal and peak outputs ( kinetic analyses could be made. For example, in the fractional linear transformation described in one of these studies,9 only two of three points fell on the line from which Km and Vmax were reported. Moreover, it is not certain that the supramaximal doses did not cause some reduction in maximal output.
To avoid the deficiencies of prior dose-response studies, we used four doses of pentagastrin which were close enough to each other to calculate Vmax and Km reliably. Moreover, the exponential model also uses the zero dose point (basal secretion), providing five data points for analysis, and allowed us to divide ED50 into its components, T and Km. By this analysis we avoided a possibly misleading conclusion that pepsin or chloride secretion are more sensitive to stimulifor example, Km in Table  1 a conclusion which results from the fact that basal:maximal ratios are higher for these two constituents and Km a smaller proportion of ED50. Thus, though Km ranged from 15 for pepsin to 76 for acid, in fact ED50 was the same for acid, chloride, and pepsin in intact man.
The dose responses provide further insights into other effects of vagotomy on gastric secretion. The reduction in Vmax and the simultaneous increase in EDsS describes the effect of vagotomy as uncompetitive rather than competitive, as in the dog where there is no basal secretion.1 2 The decrease in sensitivity of the gastric mucosa to pentagastrin is, in fact, much greater than that reflected by the two to three-fold increase in ED50 (for the new, lower Vmax). If one calculates the amount of exogenous pentagastrin required to stimulate output to 50% of its prevagotomy maximum, then increases of sixfold (for acid) and 12-fold (for pepsin) reflect the reduced sensitivity of the mucosa. The tetragastrin dose responses of Csendes et a 15 reflect an almost identical change in acid secretion. These figures tell why vagotomy is such an effective long-term treatment for duodenal ulcer.
Three cholinergic drugs have been used in the type of study reported here. Payne and Kay6 used mecholyl with restoration of histamine-stimulated MAO to 75-100% of prevagotomy output in five patients. Broome16 used carbachol in 10 antrectomised patients, restoring maximum acid output to prevagotomy levels in seven. Roland et al,'9 also using carbachol in patients with fundic vagotomy, but intact antrum, restored only two of nine patients to prevagotomy pentagastrin maximum acid output.
Roland et al later8 9 again found carbachol as well as urecholine (60 ug/kg/h) to have no effect on maximum acid output stimulated by 15 jig pentagastrin/kg/h. Urecholine, however, restored pepsin output to levels not different from prevagotomy.8 In the present study with urecholine, both acid and pepsin secretion were restored to levels not significantly different from prevagotomy controls. Thus, of the four studies which reported the use of cholinergic agents after vagotomy, there is only one laboratory3 l where cholinergic drugs failed to improve stimulation of acid secretion. The causes for the discrepancies are not obvious. Carbachol has potent nicotinic as well as ganglionic effects16 and is thus probably the wrong choice of cholinergic drug to study muscarinic effects on the stomach. Mecholyl has fewer nicotinic effects but more cardiovascular effects than the other cholinergic agonists and is thus also less suited than urecholine to studies of gastric function. Another difference between the studies of Broome16 and of Roland et a119 is the absence of antrum in the former studies, raising the possibility of an inhibitor released from the antrum (? antral chalone) by carbachol. More studies with bethanechol and appropriate dose responses are needed.
We have sought to define the effects of fundic vagotomy on acid and pepsin secretion both by the pentagastrin dose responses and by cholinergic replacement. The effect of vagotomy on the gastric responses to non-cholinergic stimuli is immediate. Subsequently, in both man and animals, there is a trend to recovery rather than to further loss of responsiveness. In man maximum acid output remains depressed from 30 to 50%, but, up to five or more years later, there is no further deterioration.7 There is thus no evidence that vagotomy causes involution or atrophy of the gastric secretory mucosa. Because the effects of vagotomy are immediate and there is restoration in most by cholinergic agents to prevagotomy acid6 16 and pepsin responses8 (and this study), we conclude that the effects of vagotomy are functional in man, as they are in the dog,1 2 and presumably result from loss of acetylcholine. Effects similar to those of vagotomy can be produced in man by atropine. 14 The therapeutic effects of vagotomy thus rest on the marked reduction of basal acid and pepsin secretion and the six-and 12-fold increase in the amount of exogenous pentagastrin, and presumably endogenous secretagogues, which would be required to stimulate the stomach to secrete acid and pepsin respectively at rates of 50% of preoperative maximum outputs. With such effective brakes on secretion, ulcer recurrence is indeed rare after adequate vagotomy. 
